Respiratory and Sleep — All Questions

Which of the following does not contribute to the stress of commercial driving?

Which of the following statements about supplemental oxygen use for CMV drivers is correct?

According to the FMCSA advisory recommendations, what AHI threshold is associated with moderate-to-severe obstructive sleep apnea that may require treatment documentation for certification?

Which of the following best describes the FMCSA standard for drivers with pulmonary tuberculosis?

A driver with asthma uses an albuterol inhaler several times a day and has not seen a physician in over a year. What should the Medical Examiner do?

A driver experienced a pneumothorax 4 weeks ago and has not yet been cleared by the treating provider. What should the Medical Examiner do?

Which of the following statements about respiratory conditions and CMV driver qualification is FALSE?

A driver presents with a pneumothorax that occurred 3 weeks ago. Records show the pneumothorax has not fully resolved. What should the Medical Examiner do?

What documentation is required from the treating provider for a CMV driver using CPAP therapy for obstructive sleep apnea?

A CMV driver presents for recertification and reports a new diagnosis of moderate obstructive sleep apnea, treated with CPAP. The driver reports good compliance and no daytime sleepiness. What is the appropriate action?

According to FMCSA guidelines, what is the primary concern regarding obstructive sleep apnea (OSA) in commercial motor vehicle (CMV) drivers?

A 52-year-old truck driver has a BMI of 38, a neck circumference of 18 inches, and reports loud snoring. According to FMCSA screening recommendations, what should the medical examiner do?

A CMV driver diagnosed with moderate obstructive sleep apnea has been prescribed CPAP therapy. According to FMCSA guidance, how should the ME assess treatment adequacy?

Which of the following BEST describes the FMCSA approach to a driver with well-controlled asthma?

A driver presents with a diagnosis of COPD and an FEV1/FVC ratio of 55%. What should the medical examiner consider?

A driver with OSA reports they stopped using their CPAP machine 3 months ago because ‘they feel fine.’ How should the medical examiner proceed?

According to FMCSA standards, a driver who has had a spontaneous pneumothorax should NOT be certified until:

According to FMCSA guidance, which severity level of obstructive sleep apnea is the primary focus for certification considerations?

A driver on supplemental oxygen therapy at rest can be certified to operate a CMV under FMCSA guidelines if:

A driver diagnosed with severe OSA (AHI of 42) has been using an oral appliance instead of CPAP. Under what condition might this be acceptable for certification?

A CMV driver has been diagnosed with asthma and uses a rescue inhaler approximately 4 times per week. What concern should the medical examiner have?

A driver with COPD presents with an FEV1 that is 45% of predicted. What is the most appropriate action for the medical examiner?

A driver with a history of tuberculosis (TB) completed treatment 2 years ago. What documentation should the medical examiner review for certification?

Which type of sleep study can be performed at home and is increasingly accepted for diagnosing uncomplicated OSA in CMV drivers?

A driver diagnosed with mild OSA (AHI of 10) who is not excessively sleepy may be certified under what conditions?

A driver with a tracheostomy who breathes independently without a ventilator can be considered for CMV certification if:

What are potential consequences of untreated moderate-to-severe obstructive sleep apnea for a CMV driver?

A driver presents with a chest X-ray showing a solitary pulmonary nodule found incidentally. How should the medical examiner approach certification?

A CMV driver reports occasional use of over-the-counter diphenhydramine (Benadryl) for seasonal allergies. What should the medical examiner advise?

A driver with cystic fibrosis is applying for CMV certification. What factors should the medical examiner primarily consider?

A driver with severe OSA wants to use an auto-titrating CPAP (APAP) instead of a fixed-pressure CPAP. Is this acceptable for FMCSA certification?

Which of the following findings on physical examination would be LEAST suggestive of OSA risk?

A CMV driver who previously required CPAP for OSA has lost 60 pounds and his BMI is now 26. He wants to stop using CPAP. What should the examiner require?

What spirometry pattern would you expect in a driver with emphysema?

A CMV driver is using bilevel positive airway pressure (BiPAP) for treatment of overlap syndrome (COPD + OSA). What compliance documentation should the examiner review?

According to FMCSA advisory criteria, which of the following conditions has the HIGHEST risk of sudden incapacitation from a respiratory standpoint?

A driver has been diagnosed with idiopathic pulmonary fibrosis (IPF). What is the medical examiner’s primary concern regarding CMV certification?

What is the recommended approach for a CMV driver who has undergone a lung resection (lobectomy) for lung cancer?

During a DOT physical examination, the medical examiner measures the driver’s oxygen saturation at 89% at rest. What is the appropriate next step?

Which of the following is TRUE regarding the use of theophylline in a CMV driver with COPD?

A driver with a BMI of 42 denies snoring and daytime sleepiness but has never been evaluated for OSA. Should the medical examiner still screen for OSA?

A CMV driver with well-controlled asthma asks whether they need to carry their rescue inhaler in the truck. What should the medical examiner advise?

Which of the following chest wall conditions could cause restrictive pulmonary impairment in a CMV driver?

What AHI level defines severe obstructive sleep apnea?

A driver with a pleural effusion detected on chest X-ray should be evaluated for what conditions before certification?

Which of the following is the MOST important factor in determining whether a CMV driver with COPD can be certified?

A CMV driver complains of excessive daytime sleepiness but a sleep study shows an AHI of only 3 (normal). What should the medical examiner consider?

A driver presents with a chronic cough that produces blood-tinged sputum (hemoptysis). What should the medical examiner do?

Which physical examination finding is associated with chronic COPD that the medical examiner may observe?

A CMV driver underwent bariatric surgery 1 year ago and has lost significant weight. His previous severe OSA diagnosis may need to be re-evaluated. What test should be ordered?

According to FMCSA guidelines, how should a medical examiner approach a driver with well-controlled allergic rhinitis?

A driver states they have been diagnosed with exercise-induced asthma only. How does this affect CMV certification?

What is the importance of evaluating a CMV driver’s smoking history during the DOT physical?

A CMV driver presents with a new diagnosis of pneumonia. When can they be recertified after treatment?

A CMV driver with treated OSA reports that they travel frequently and sometimes forget their CPAP machine at home. What should the examiner advise?

Which respiratory condition is considered an absolute disqualification for CMV driving under FMCSA standards?

A driver with OSA uses a mandibular advancement device (MAD) instead of CPAP. What is the key documentation the examiner needs?

Which of the following conditions is most likely to cause both OSA and pulmonary hypertension in a CMV driver?

A CMV driver with stable, mild persistent asthma is using an inhaled corticosteroid (ICS) daily and an albuterol rescue inhaler as needed. Is this medication regimen compatible with CMV certification?

A driver with well-controlled asthma using an inhaled bronchodilator should receive what determination?

According to FMCSA guidance, what does the ME need to determine about a driver’s OSA treatment before certification?

Use of supplemental oxygen while driving a CMV is considered what?

A 45-year-old hazmat tanker driver reports recurrent chemical inhalation exposures during loading operations. Spirometry shows a new obstructive pattern with FEV1/FVC ratio of 0.62. What should the medical examiner prioritize in the FMCSA certification evaluation?

What is the primary occupational respiratory risk factor that FMCSA medical examiners should consider when evaluating drivers who frequently transport grain products?

A 34-year-old CMV driver had a primary spontaneous pneumothorax treated with chest tube drainage 4 months ago. There has been no recurrence. What is the most appropriate FMCSA certification decision?

A CMV driver has a history of two recurrent spontaneous pneumothoraces on the right side, both managed with chest tubes. He has declined surgical pleurodesis. How should the FMCSA medical examiner approach certification?

A driver presents 8 weeks after a secondary spontaneous pneumothorax caused by underlying COPD. CT shows residual bullous disease. What finding would MOST concern the FMCSA medical examiner regarding recurrence risk?

A driver with restrictive lung disease from prior thoracic surgery has an FVC of 55% predicted but reports being able to perform all job duties. Pulmonary rehabilitation records show stable functional capacity. How should the medical examiner approach this case under FMCSA guidelines?

During a CMV certification exam, a driver with interstitial lung disease demonstrates oxygen desaturation to 86% during a supervised walk test after pulmonary rehabilitation. The driver states he only drives short routes and rarely exits the cab. What is the appropriate FMCSA determination?

A CMV driver with supplemental oxygen-dependent pulmonary fibrosis asks about certification for routes through Denver, Colorado (elevation 5,280 feet). Under FMCSA guidelines, what is the primary certification concern?

A CMV driver presents for recertification 6 months after sustaining bilateral rib fractures and a left hemothorax in a motor vehicle accident. Chest X-ray shows healed fractures with no residual effusion. What must the FMCSA medical examiner verify before recertification?

If left untreated, moderate-to-severe obstructive sleep apnea may contribute to which deficits that interfere with CMV driving?

Do the FMCSRs require MEs to screen individuals for obstructive sleep apnea?

FMCSA recommends using which approach to identify individuals at risk for moderate-to-severe OSA?

Which of the following is NOT listed as a risk factor for obstructive sleep apnea in the handbook?

If treated appropriately, does moderate-to-severe OSA preclude CMV certification?

When is retesting for OSA warranted in an individual previously diagnosed with moderate-to-severe OSA treated with CPAP?

Do the FMCSRs specify preferred diagnostic testing methods, treatment methods, or compliance requirements for OSA?

A driver previously tested negative for OSA but now presents with significant weight gain, new onset hypertension, and excessive daytime sleepiness. Should the ME recommend another sleep study?

OSA guidelines referenced in the 2024 handbook regarding screening and certification are classified as what type of guidance?

Which respiratory conditions are specifically listed as conditions that may interfere with oxygen exchange and safe CMV operation?

What are the cardinal symptoms of COPD that an ME should assess during a physical qualification examination?

What is the primary etiologic factor in the majority of COPD cases?

Which finding during the physical examination of a driver with a respiratory condition should prompt further pulmonary function evaluation?

What should be the focus of the ME’s evaluation for a driver with an unstable COPD condition?

Medications used to treat respiratory conditions, both prescription and over-the-counter, may cause which effects relevant to CMV safety?

First generation antihistamines used to treat respiratory congestion may have what effect that concerns CMV safety?

How should allergic rhinitis in a CMV driver typically be managed?

An individual with asthma reports well-controlled symptoms on bronchodilator therapy with no interference with daily activities. How should the ME approach certification?

Untreated moderate-to-severe OSA is associated with which additional health risks beyond excessive sleepiness?

A driver diagnosed with moderate OSA is being treated with bilevel positive airway pressure (BiPAP). The treatment is documented as effective and stable. What is the certification determination?

Is OSA a condition that requires testing on a regular schedule according to the handbook?

Cystic fibrosis treatment may require which ongoing interventions that could affect CMV driving ability?

When evaluating a driver with interstitial lung disease, what should the ME assess beyond the ILD diagnosis itself?

Pneumothorax following trauma requires which documentation to confirm complete recovery before CMV certification?

Acute infectious respiratory diseases such as influenza or bronchitis generally have what impact on CMV certification?

FMCSA recommends that MEs identify individuals at risk for moderate-to-severe OSA by evaluating which approach?

Obesity and high BMI are listed as risk factors for which condition that may affect CMV driver safety?

The FMCSRs include mandatory requirements for MEs to screen all drivers for obstructive sleep apnea.

Untreated moderate-to-severe OSA may contribute to which specific driving-related danger?

When counseling a driver about the risks of untreated moderate-to-severe obstructive sleep apnea, which deficits should the ME emphasize?

A driver with treated moderate-to-severe OSA on CPAP reports that symptoms have returned. What guidance does the handbook provide about retesting?

Which of the following is NOT listed as an OSA risk factor that the ME should consider during a physical examination?

What effect can irregular meal timing and extended work hours have on a CMV driver taking scheduled medications?

A driver presents for evaluation after a prior sleep study showed only mild OSA. He reports no changes in risk factors or symptoms since that study. Should the ME recommend a new sleep study?

A driver with diagnosed moderate OSA on CPAP therapy presents for certification. Which question should the ME consider?

Which medications used to treat respiratory conditions may compound the risk of excessive daytime sleepiness in CMV drivers?

A 55-year-old driver with a BMI of 38, large neck circumference, hypertension, and type 2 diabetes reports loud snoring and daytime sleepiness. He has never had a sleep study. What should the ME consider?

A 60-year-old driver taking oxycodone for chronic back pain drives 10 hours per day with irregular meal times and poor sleep. Which combination of factors should concern the ME most?

A driver with a BMI of 42, type 2 diabetes, and hypertension is being evaluated. Which of the following best describes the relationship between obesity and driving risk?

A driver with both a right hand finger amputation (lost ring and pinky fingers) and mild COPD presents for recertification. The driver can grip the steering wheel but reports reduced ability to manipulate small dashboard switches. Spirometry shows FEV1 at 65% predicted. How should the ME integrate these findings?

What is the FIRST action an EMT should take upon arriving at any emergency scene?

You are dispatched to a domestic disturbance where a patient reportedly has a stab wound. Upon arrival, you hear yelling from inside the residence and see broken glass on the front porch. What should you do?

You respond to a call at a warehouse where a worker has collapsed. As you approach, a coworker runs toward you shouting that there is a strong chemical odor inside. What is your most appropriate action?

A patient started on methotrexate 15 mg weekly for rheumatoid arthritis asks the pharmacy technician why the pharmacist also prescribed folic acid 1 mg daily. What is the purpose of folic acid supplementation with methotrexate?

A hospital pharmacy technician is preparing a heparin drip for a patient in the ICU. The order calls for heparin 25,000 units in 500 mL D5W. The technician has access to both heparin 1,000 units/mL vials and heparin 10,000 units/mL vials. Which safety practice is most important when selecting the correct vial?

A pharmacy technician in a community pharmacy receives a prescription for nifedipine ER 60 mg daily. The patient mentions they have been biting and swallowing their previous nifedipine 10 mg capsules when they feel their blood pressure is high. What danger does this practice present that the technician should immediately relay to the pharmacist?

A pharmacy technician notices that a carton of brand-name atorvastatin received from a secondary wholesaler lacks a product identifier with a unique serial number on individual packages. Under the DSCSA’s enhanced drug distribution security requirements, why is this a compliance concern?

A pharmacy technician in a hospital setting is asked to prepare a phenytoin dose for a patient receiving enteral nutrition through a nasogastric tube. The order calls for phenytoin suspension 300 mg via NG tube. The technician knows the patient’s tube feeding was held for the required time. What additional consideration regarding the dosage form is most important?

A pharmacy receives a Class II recall notice for a specific lot of lisinopril 10 mg tablets due to incorrect labeling that lists the wrong strength on the bottle. The recall notice indicates lot number AB1234 with an expiration date of 09/2027. The technician finds three bottles in stock: one with lot AB1234 (exp 09/2027), one with lot AB1235 (exp 11/2027), and one with lot AB1233 (exp 07/2027). Which bottle(s) should be quarantined?

A prescriber writes for metoprolol succinate ER 100 mg daily for a patient with heart failure. The pharmacy only has metoprolol tartrate 50 mg tablets in stock. What should the pharmacy technician understand about substituting between these two formulations?

A pharmacy technician processing a prescription for mifepristone notices the pharmacy is not listed as a certified prescriber site in the Mifepristone REMS program. What does this mean for dispensing?

A pharmacy technician at a specialty pharmacy reviews a new prescription for simeprevir for hepatitis C. The patient’s profile lists carbamazepine 400 mg twice daily for seizure disorder. The technician recalls that carbamazepine is a strong CYP3A4 inducer. What is the expected outcome if both medications are taken together?

A pharmacy technician discovers that 30 tablets of oxycodone 30 mg are missing during a biennial controlled substance inventory. The perpetual inventory log shows no dispensing that would account for the shortage. What is the pharmacy’s obligation under DEA regulations?

A hospital pharmacy technician processes orders for a patient receiving IV vancomycin and oral metformin. The patient’s latest serum creatinine is 2.1 mg/dL, up from 0.9 mg/dL at admission. Considering the drug interaction potential, why is this lab change particularly concerning for the metformin order?